Waleed Al Mokarrab Al Muhairi
Chairman, Waha Capital
Mr. Al Muhairi serves as Mubadala’s Deputy Group Chief Executive Officer and has strategic oversight of the company’s broad investment portfolio and special projects at the group level. He is also a member of the investment committee, which is mandated to develop Mubadala’s investment policies, establish investment guidelines, and review proposed projects and investments to ensure they are in line with business objectives.
Mr. Al Muhairi is also the Chairman to Mubadala's new investment and business planning committee, which approves transactions within certain financial thresholds in addition to having the responsibility of annual and multi-year business planning. Furthermore, Mr. Al Muhairi has oversight of the Real Estate & Infrastructure Investments and Diversified Investments platforms.
Prior to joining Mubadala, Mr. Al Muhairi worked with the UAE Offsets Programme Bureau as a Senior Project Manager. Past roles also include working with McKinsey & Company as a consultant.
Mr. Al Muhairi is the Chairman of Waha Capital, Mubadala Capital, Global Institute for Disease Elimination (GLIDE), and the US-UAE Business Council. In addition, Mr. Al Muhairi is the first Vice Chairman of Aldar, and a member of the Board of Trustees of Cleveland Clinic in the United States. He is also a board member of First Abu Dhabi Bank (FAB), Hub71, Ellipses Pharma Limited, Abu Dhabi Investment Council, Investcorp, and M42.
Mr. Al Muhairi holds a Master’s Degree in Public Policy from Harvard University, and a Bachelor of Science Degree in Foreign Service in Economics and Finance from Georgetown University, USA.